Mitigation of Chromosome Loss in Clinical CRISPR-Cas9-Engineered T Cells

To investigate whether Cas9-induced chromosome loss is a universal phenomenon and evaluate its clinical significance, the authors conducted a systematic analysis in primary human T cells.